Free Trial

Aileron Therapeutics (ALRN) SEC Filings & 10K Form

Aileron Therapeutics logo
$2.55 -0.21 (-7.61%)
(As of 10:17 AM ET)

Recent Aileron Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:03 PM
Aileron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
4:17 PM
Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
Form SCHEDULE 13G/A
08/22/2024
3:05 PM
Aileron Therapeutics (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM
Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM
Aileron Therapeutics (Issuer)
Fairey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:07 PM
Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:09 PM
Aileron Therapeutics (Issuer)
Aivado Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
4:12 PM
Aileron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
4:23 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:29 PM
Aileron Therapeutics (Filer)
Form 424B5
07/26/2024
3:33 PM
Aileron Therapeutics (Filer)
Form 424B5
07/26/2024
3:36 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
7:41 AM
Aileron Therapeutics (Filer)
Form ARS
07/09/2024
7:30 AM
Aileron Therapeutics (Filer)
Form DEF 14A
07/09/2024
7:36 AM
Aileron Therapeutics (Filer)
Form DEFA14A
06/17/2024
6:03 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
5:18 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:59 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:58 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:19 PM
Aileron Therapeutics (Issuer)
Cunningham Timothy M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/15/2024
4:16 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:54 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4/A
05/01/2024
6:15 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
4:24 PM
Aileron Therapeutics (Filer)
Form 424B5
05/01/2024
4:25 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
4:16 PM
Aileron Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:40 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:54 AM
Aileron Therapeutics (Subject)
Form FWP
04/30/2024
2:32 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/29/2024
7:33 AM
Aileron Therapeutics (Filer)
Form 10-K/A
04/16/2024
4:16 PM
Aileron Therapeutics (Subject)
Satter Muneer A (Filed by)
Form SC 13D/A
04/15/2024
4:21 PM
Aileron Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
4:22 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:15 PM
Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4/A
04/10/2024
3:15 PM
Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4/A
04/02/2024
5:10 PM
Aileron Therapeutics (Issuer)
Garner Charles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
3:15 PM
Aileron Therapeutics (Filer)
Form NT 10-K
03/29/2024
7:03 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
6:00 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:06 PM
Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:14 PM
Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by)
Form SC 13G
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
03/01/2024
3:05 PM
Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:05 PM
Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:01 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
9:28 AM
Aileron Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/13/2024
6:01 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
11:15 PM
Aileron Therapeutics (Filer)
Form EFFECT
02/05/2024
12:20 PM
Aileron Therapeutics (Subject)
Kapnick Scott (Filed by)
Form SC 13G/A
01/29/2024
7:46 AM
Aileron Therapeutics (Filer)
Form DEF 14A
01/29/2024
7:48 AM
Aileron Therapeutics (Filer)
Form ARS
01/29/2024
7:14 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
6:00 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:44 PM
Aileron Therapeutics (Filer)
Form PRE 14A
01/11/2024
3:18 PM
Aileron Therapeutics (Filer)
Form 8-K/A
01/10/2024
3:08 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
4:56 PM
Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:43 PM
Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALRN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners